Nike Stock Hits 9-Year Low as Turnaround Doubts Intensify Ahead of Earnings

What happened

Nike's stock has plummeted to a nine-year low as skepticism mounts over its turnaround efforts ahead of the upcoming earnings report. The DeepValue report outlines a multi-quarter reset focused on margin recovery through cost cuts and reduced liquidation, but progress remains slow with gross margins down 300 basis points year-over-year to 40.6% in Q2 FY26 due to tariff pressures. Persistent weakness in Greater China, which represents about 15% of sales, adds to the headwinds, challenging management's ability to stabilize key markets. The new article reinforces these concerns by highlighting analyst views that new products are failing to resonate with consumers, undermining growth initiatives. With a $300 million restructuring charge expected in Q3 FY26 and questions about innovation, Nike faces critical tests to prove its strategy can regain traction.

Implication

The stock's drop to nine-year lows signals eroding market confidence, suggesting that Nike's current valuation may not fully account for the risks of a protracted turnaround. Upcoming earnings must show disciplined operating overhead control and clarity on whether restructuring charges will recur beyond the initial $300 million, as highlighted in the report's downside risks. Failure to demonstrate product relevance or China recovery could trigger further analyst downgrades and price pressure, aligning with the bear case scenario of flat EBIT and margin stagnation. Conversely, any signs of a cleaner marketplace and full-price mix recovery in the second half of FY26 could validate the wait-and-see approach, but given the high P/E of 32.1, the margin of safety remains thin. Overall, the lack of product traction amplifies the urgency for Nike to deliver on its turnaround promises, reinforcing the report's recommendation to avoid premature investment until proof points emerge.

Thesis delta

The new article confirms the product relevance concerns already embedded in the DeepValue report, but it does not fundamentally shift the core thesis of waiting for observable improvements in gross margins and China demand. However, it heightens the near-term scrutiny on Nike's innovation pipeline, making the upcoming earnings a more critical checkpoint for assessing whether management can address these gaps effectively.